Showing results (1071-1080 of 1,241) with videos related to

Sort By:
Pageof 125
Cytometry. Part B, Clinical Cytometry|April 18, 2012
Flow cytometry-based assessment of mitoxantrone efflux from leukemic blasts varies with response to induction chemotherapy in acute myeloid leukemiaHyun Pyo Kim, Lea Bernard, Jonathan Berkowitz, et al.
Cytometry. Part B, Clinical Cytometry|April 18, 2012
Evaluation of flow cytometric assessment of myeloid nuclear differentiation antigen expression as a diagnostic marker for myelodysplastic syndromes in a series of 269 patientsFrauke Bellos, Tamara Alpermann, Elena Gouberman, et al.
Cytometry. Part B, Clinical Cytometry|February 14, 2012
Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemiaMarianne Hutchings Hoffmann, Tobias Wirenfeldt Klausen, Martin Boegsted, et al.
Cytometry. Part B, Clinical Cytometry|November 29, 2014
Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomasAlessandra Stacchini, Donatella Pacchioni, Anna Demurtas, et al.
Cytometry. Part B, Clinical Cytometry|November 11, 2014
Optimizing of the basophil activation test: Comparison of different basophil identification markersBernadette Eberlein, Rebekka Hann, Stefanie Eyerich, et al.
Cytometry. Part B, Clinical Cytometry|October 24, 2014
Dextramer reagents are effective tools for quantifying CMV antigen-specific T cells from peripheral blood samplesJoseph D Tario, George L Chen, Theresa E Hahn, et al.
Cytometry. Part B, Clinical Cytometry|October 21, 2014
Stable phenotype of B-cell subsets following cryopreservation and thawing of normal human lymphocytes stored in a tissue biobankSimon Mylius Rasmussen, Anders Ellern Bilgrau, Alexander Schmitz, et al.
Cytometry. Part B, Clinical Cytometry|November 18, 2014
Optimizing of the basophil activation test: Comparison of different basophil identification markersBernadette Eberlein, Rebekka Hann, Stefanie Eyerich, et al.
Cytometry. Part B, Clinical Cytometry|October 24, 2013
Tumor heterogeneity makes AML a "moving target" for detection of residual diseaseW Zeijlemaker, J W Gratama, G J Schuurhuis
Cytometry. Part B, Clinical Cytometry|October 15, 2013
ZAP70 in B-CLL cells related to the expression in NK cells is a surrogate marker for mutational statusTom G H Wiggers, Guus Westra, Theresia M Westers, et al.
Pageof 125